Cost-Effectiveness of Ceftriaxone and Levofloxacin Use in Pneumonia Patients at Army Hospital Indonesia
DOI:
https://doi.org/10.18196/mmjkk.v25i2.21348Keywords:
pneumonia, cost effectiveness analysis, levofloxacin, ceftriaxone, antibioticsAbstract
Pneumonia is a common respiratory tract infection worldwide and a serious issue in Indonesia, especially in Jakarta. Given the significant burden of pneumonia in Jakarta, periodic pharmacoeconomic evaluations of inpatient treatment are essential to support evidence-based policymaking. This study aims to compare the cost-effectiveness of levofloxacin and ceftriaxone, commonly used for pneumonia treatment. This study is an observational analysis using a cross-sectional method on 58 samples selected by a purposive sampling technique. The results indicate that levofloxacin provides more leukocyte reduction than ceftriaxone, and there were significant differences (p = 0.033). Although ceftriaxone therapy has a lower average direct medical cost than levofloxacin, there is no significant difference in the average direct medical cost of both therapies (p = 0.944). However, levofloxacin therapy has a lower Average Cost-Effectiveness Ratio (ACER) value of IDR 1,410.58 compared to ceftriaxone, making it more cost-effective. Switching from ceftriaxone to levofloxacin requires an additional IDR 64.00 to reduce 1 μL of leukocyte cells. Therefore, levofloxacin is concluded to be more cost-effective for treating pneumonia patients in inpatient care at Gatot Soebroto Army Hospital, Indonesia.
References
Seeger, A., & Rohde, G. (2023). Ambulant erworbene Pneumonie [Community-acquired pneumonia]. Deutsche medizinische Wochenschrift, 148(6), 335–341. https://doi.org/10.1055/a-1940-8944
Perhimpunan Dokter Paru Indonesia. Panduan Umum Praktik Klinis Penyakit Paru dan Pernapasan. Kosasih A, Sutanto Yusup S, Susanto Agus D, editors. Jakarta: PDPI; 2021. p.26–38. Available from: https://bukupdpi.klikpdpi.com/buku-pupk-pdpi-2021-2/
Kandou RD, Lantu MG, Loho E, Ali RH. Gambaran foto toraks pada efusi pleura di Bagian/SMF Radiologi FK Unsrat RSUP Prof. J e-Clinic (eCl) [Internet]. 2016;4. Available from: https://ejournal.unsrat.ac.id/index.php/eclinic/article/view/10966
Regunarth H, Oba Y. Community-Acquired Pneumonia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430749/
Lorenz, J., & Ewig, S. (2016). Ambulant erworbene Pneumonie. Update 2016 der S3-Leitlinie [Community-acquired pneumonia]. Deutsche medizinische Wochenschrift (1946), 141(7), 486–489. https://doi.org/10.1055/s-0042-102330
Jain V, Vashisht R, Yilmaz G. Pneumonia Pathology. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 . Available from: https://www.ncbi.nlm.nih.gov/books/NBK526116/
Aldehita. Studi Penggunaan Obat Antibiotik pada Pasien Pneumonia di RS Hj. Bunda Halimah Kota Batam. J Kesehatan Pharmasi (JKPharm). 2022;1. Available from: https://jurnal.poltekkespalembang.ac.id/index.php/Jkpharm/article/view/1252
Whalen K. Lippincott Illustrated Reviews: Pharmacology. 7th ed. Sharma S, Velpandian T, editors. Journal of Chemical Information and Modeling; 2019;53. https://books.google.co.id/books/about/Lippincott_Illustrated_Reviews_Pharmacol.html?id=Xr-CEAAAQBAJ&redir_esc=y
Katzung BG, Masters SB, Trevor AJ. Farmakologi Dasar & Klinik. 12th ed. Soeharsono R, editor. Jakarta: Penerbit Buku Kedokteran EGC; 2014. https://elib.kedokteran.unpas.ac.id/index.php?p=show_detail&id=683
Alifiar I, Idacahyati. Kajian Farmakoekonomi Penggunaan Obat Antihipertensi pada Pasien Hipertensi di RSUD Kota Tasikmalaya. J Pharmascience [Internet]. 2018;5(2):126–33. Available from: https://www.researchgate.net/publication/329235646_Kajian_Farmakoekonomi_Penggunaan_Obat_Antihipertensi_pada_Pasien_Hipertensi_yang_Dirawat_di_RSUD_Kota_Tasikmalaya
Bang H, Zhao H. Cost-effectiveness analysis: A proposal of new reporting standards in statistical analysis. J Biopharm Stat. 2014 Mar 4;24(2):443–60. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3955019/
Andayani TM. Farmakoekonomi: Prinsip dan Metodologi. Yogyakarta: Bursa Ilmu; 2013.
Fatin MNA, Rahayu C, Suwantika AA. Analisis Efektivitas Biaya Penggunaan Antibiotik pada Pasien Community-Acquired Pneumonia di RSUP Dr. Hasan Sadikin Bandung. Indones J Clin Pharm. 2019 Sep 29;8(3). Available from: https://jurnal.unpad.ac.id/ijcp/article/view/22428
Kementerian Kesehatan RI. Pedoman penerapan kajian Farmakoekonomi. Sarnianto P, Gusnellyanti E, Fadia Z, editors. Jakarta: Kemenkes RI; 2013. Available from: https://farmalkes.kemkes.go.id/unduh/pedoman-penerapan-kajian-farmakoekonomi/
Wulandari DN. Efektivitas Penggunaan Antibiotik Ceftriaxone pada Pasien Pneumonia Dewasa di RSUD Dr. Moewardi Surakarta Tahun 2014–2015 [Bachelor Thesis]. Surakarta: Universitas Sebelas Maret; 2016. Available from: https://core.ac.uk/download/pdf/211750817.pdf
Henig O, Kaye KS. Bacterial Pneumonia in Older Adults. Infect Dis Clin North Am. 2017;31:689–713. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7127502/
Erickson MA, Banks WA. Age-associated changes in the immune system and blood–brain barrier functions. Int J Mol Sci. 2019;20. Available from: https://pubmed.ncbi.nlm.nih.gov/30986918/
Ulfa CF, Supadmi W, Perwitasari D, Yuniarti E. Hubungan Ketepatan Peresepan Antibiotik dengan Metode Gyssens dengan Perbaikan Klinis Pasien Pneumonia Komunitas. Yogyakarta; 2021 Apr. Available from: http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/download/940/559/
Hammond A, Halliday AV, Thornton HV, Hay AD. Predisposing factors to acquisition of acute respiratory tract infections in the community: a systematic review and meta-analysis. BMC Infect Dis. 2021 Dec 1;21(1). Available from: https://pubmed.ncbi.nlm.nih.gov/34906101/
Chamekh M, Deny M, Romano M, Lefèvre N, Corazza F, Duchateau J, et al. Differential susceptibility to infectious respiratory diseases between males and females linked to sex-specific innate immune inflammatory response. Front Immunol. 2017;8. Available from: https://pubmed.ncbi.nlm.nih.gov/29321783/
Rahmawati C, Lenysia B, Anjani P, Furqani N. Cost-Effectiveness Analysis Penggunaan Ceftriaxone Dibandingkan dengan Levofloxacin Pada Pasien Community Acquired Pneumonia di RSUD Provinsi NTB. J Ilmu Kefarmasian. 2023;4(1). Available from: https://journal.ummat.ac.id/index.php/farmasi/article/view/13164
Aprialdi B, Harfiani E, Yusmaini H. Perbandingan Pemberian Seftriakson dan Levofloksasin terhadap Kadar Kreatinin Serum Pasien Pneumonia Rawat Inap di RS Citra Sari Husada Karawang. Seminar Nasional Riset Kedokteran. Available from: https://conference.upnvj.ac.id/index.php/sensorik/article/view/431
Subrahmanyam NS, Tagoore D, Lakshmi V, Raju GVN, Pavan Kumar GV. Cefotaxime Induced Macular Rash Case Report. Saudi J Med Pharm Sci [Internet]. 2018. Available from: https://saudijournals.com/media/articles/SJMPS_49_1032-1034_c.pdf
Yadegarynia D, Tehrani S, Nejad FM, Shojaeian F, Keyvanfar A. Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study [Internet]. 2022 ;14. Available from: https://pubmed.ncbi.nlm.nih.gov/36721509/
Meriyani H, Megawati F, Udayani NW. Efektivitas Terapi Pneumonia pada Pasien Pediatrik di RSUP Sanglah Denpasar Ditinjau dari Parameter Respiration Rate. J Ilmiah Medicamento. 2016;2. Available from: https://www.neliti.com/id/publications/329120/efektivitas-terapi-pneumonia-pada-pasien-pediatrik-di-rumah-sakit-umum-pusat-san
Lardo S, Chen LK, Santoso WD, Rumende CM. Hubungan Kualitas Penggunaan Antibiotik Menggunakan Alur Gyssens dengan Keberhasilan Pengobatan pada Sepsis MDR Gram Negatif. J Penyakit Dalam Indones. 2021;7(4):221. Available from: https://scholar.ui.ac.id/en/publications/hubungan-kualitas-penggunaan-antibiotik-menggunakan-alur-gyssens-
Aoralia S. Cost-Effectiveness Analysis Penggunaan Antibiotik Levofloxacin dan Ceftriaxone untuk Mengatasi Penyakit Pneumonia di RS Islam Sultan Agung Semarang [Bachelor Thesis]. Semarang: Universitas Islam Sultan Agung; 2022. Available from: https://repository.unissula.ac.id/25250/
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhamad Iqbal Husaini, Erna Harfiani, Soroy Lardo, Hany Yusmaini
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
